Home Menu

Site Navigation



ALS News & Research For postings of news or research links and articles related to ALS


advertisement
NeuroTalk Support Groups > > > >

MT Pharma America Announces FDA Approval of RADICAVAtm (Edaravone), the First New Tre

Reply
 
Thread Tools Display Modes
Old 05-06-2017, 01:04 PM #1
MuonOne's Avatar
MuonOne MuonOne is offline
Grand Magnate
  
Join Date: Feb 2007
Posts: 3,269
15 yr Member
MuonOne MuonOne is offline
Grand Magnate
MuonOne's Avatar
 
Join Date: Feb 2007
Posts: 3,269
15 yr Member
Exclamation MT Pharma America Announces FDA Approval of RADICAVAtm (Edaravone), the First New Tre
MT Pharma America Announces FDA Approval of RADICAVA™ (Edaravone), the First New Treatment Option for ALS in More Than 20 Years

MT Pharma America Announces FDA Approval of RADICAVA™ (Edaravone), the First New Treatment Option for ALS in More Than 2 Years | Small Molecules | News Channels
MuonOne is offline   Reply With QuoteReply With Quote

advertisement
Old 05-06-2017, 01:05 PM #2
MuonOne's Avatar
MuonOne MuonOne is offline
Grand Magnate
  
Join Date: Feb 2007
Posts: 3,269
15 yr Member
MuonOne MuonOne is offline
Grand Magnate
MuonOne's Avatar
 
Join Date: Feb 2007
Posts: 3,269
15 yr Member
Exclamation FDA approves new ALS treatment
FDA approves new ALS treatment

FDA approves new ALS treatment | Duluth News Tribune
MuonOne is offline   Reply With QuoteReply With Quote
Old 05-06-2017, 01:05 PM #3
MuonOne's Avatar
MuonOne MuonOne is offline
Grand Magnate
  
Join Date: Feb 2007
Posts: 3,269
15 yr Member
MuonOne MuonOne is offline
Grand Magnate
MuonOne's Avatar
 
Join Date: Feb 2007
Posts: 3,269
15 yr Member
Exclamation FDA approves medication to treat Lou Gehrig's Disease
FDA approves medication to treat Lou Gehrig’s Disease

FDA approves medication to treat Lou Gehrig’s Disease
MuonOne is offline   Reply With QuoteReply With Quote
Old 05-06-2017, 01:07 PM #4
MuonOne's Avatar
MuonOne MuonOne is offline
Grand Magnate
  
Join Date: Feb 2007
Posts: 3,269
15 yr Member
MuonOne MuonOne is offline
Grand Magnate
MuonOne's Avatar
 
Join Date: Feb 2007
Posts: 3,269
15 yr Member
Exclamation FDA approves first new drug in 20 years to treat ALS
FDA approves first new drug in 20 years to treat ALS

FDA approves first new drug in 2 years to treat ALS
MuonOne is offline   Reply With QuoteReply With Quote
Old 05-06-2017, 01:08 PM #5
MuonOne's Avatar
MuonOne MuonOne is offline
Grand Magnate
  
Join Date: Feb 2007
Posts: 3,269
15 yr Member
MuonOne MuonOne is offline
Grand Magnate
MuonOne's Avatar
 
Join Date: Feb 2007
Posts: 3,269
15 yr Member
Exclamation FDA approves first new drug in years to treat Lou Gehrig's disease
FDA approves first new drug in years to treat Lou Gehrig's disease

FDA approves first new drug in years to treat Lou Gehrig's disease | BREAKING NEWS | Sky Valley Chronicle Washington State News
MuonOne is offline   Reply With QuoteReply With Quote
Reply

Tags
america, approval, edaravone, pharma, radicava™

« Previous Thread | Next Thread »

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts
BB code is On
Smilies are On
[IMG] code is On
HTML code is Off

Similar Threads
Thread Thread Starter Forum Replies Last Post
MT Pharma Presents Data on Edaravone for ALS at 2017 AAN Meeting MuonOne ALS News & Research 0 05-02-2017 09:06 PM
Schwarz Pharma' Neupro to get approval for treatment of Parkinson's disease Stitcher Parkinson's Disease 1 11-20-2006 03:54 PM


All times are GMT -5. The time now is 11:43 AM.

Powered by vBulletin • Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.

vBulletin Optimisation provided by vB Optimise v2.7.1 (Lite) - vBulletin Mods & Addons Copyright © 2024 DragonByte Technologies Ltd.
 

NeuroTalk Forums

Helping support those with neurological and related conditions.

 

All posts copyright their original authors.

The material on this site is for informational purposes only,
and is not a substitute for medical advice, diagnosis or treatment
provided by a qualified health care provider.

Always consult your doctor before trying anything you read here.

Home